查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1948852

鴉片市場－全球產業規模、佔有率、趨勢、機會及按類型、應用、地區和競爭格局分類的預測（2021-2031年）

Opium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Solid, Solvent), By Application (Anesthetized, Dyeing, Others), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球鴉片市場預計將從 2025 年的 93.8 億美元成長到 2031 年的 125.1 億美元，複合年成長率為 4.92%。

鴉片是從罌粟（Papaver somniferum）未成熟種子莢中提取的風乾乳膠，富含氫可酮和可待因等重要生物鹼，是製藥業的重要原料。推動市場成長的關鍵因素包括全球慢性疼痛疾病盛行率的上升以及人口老化帶來的對有效安寧療護日益成長的需求。此外，癌症治療的進步需要嚴格的疼痛管理通訊協定，從而產生了對鴉片類止痛藥的持續工業需求，這種需求將超過暫時的市場波動。

市場概覽
預測期 2027-2031
市場規模：2025年 93.8億美元
市場規模：2031年 125.1億美元
複合年成長率：2026-2031年 4.92%
成長最快的細分市場 固體的
最大的市場 北美洲

然而，市場擴張的一大障礙是為防止藥物濫用和降低成癮風險而建立的嚴格國際法規結構。這些複雜的合規要求往往會阻礙供應鏈，限制患者獲得藥物，尤其是在發展中地區。根據國際麻醉藥品管制局的數據，到2025年，全球生產的氫可酮中只有18%會直接用於鎮痛，凸顯了醫療取得方面存在的巨大差距，而這正是限制市場擴張的因素。

市場促進因素

全球人口快速老化是鴉片市場的主要促進因素，對長期疼痛管理方案的需求日益成長。隨著預期壽命的延長，與老齡化相關的退化性疾病發生率也隨之上升，從而維持了慢性病照護中對氫可酮和可待因的工業需求。根據聯合國2024年7月發布的《2024年世界人口展望》，預計65歲及以上人口將從2024年的8.25億成長到2050年的15.3億，這將形成一個龐大的患者群體，需要持續的疼痛緩解支持。這種人口結構的變化迫使製藥企業尋找可靠的鴉片類藥物原料，以確保老年人基本藥物的穩定供應，這需要建立能夠滿足老年人日益成長的醫療保健需求的供應鏈。

同時，針對癌症和末期病患的安寧療護服務的擴展正在顯著影響市場趨勢。鴉片類藥物仍是晚期疾病重度疼痛管理的標準療法，能夠保障接受治療患者的生活品質。美國癌症協會於2024年1月發布的《2024年癌症事實與數據》預測，光是在美國就將新增超過200萬例癌症病例，凸顯了對完善的疼痛管理通訊協定日益成長的需求。然而，供應動態正在改變。根據聯合國毒品犯罪防制署（UNODC）於2024年6月發布的《2024年世界毒品報告》，受阿富汗禁種令的影響，2023年全球鴉片產量下降了74%。這種不斷成長的醫療需求帶來​​了複雜的挑戰。

市場挑戰

旨在遏制非法轉移和成癮風險的嚴格國際法規結構，對全球鴉片類藥物市場的成長構成了重大障礙。這些合規通訊協定要求對整個供應鏈進行嚴格監管，要求製造商和經銷商遵守複雜的許可程序以及嚴格的進出口配額。這種繁瑣的官僚程序顯著增加了營運成本，延長了交貨時間，並限制了製藥公司應對不斷變化的醫療需求的靈活性。因此，高成本以及獲得管制藥物批准相關的行政負擔，限制了鴉片類鎮痛方案的商業性擴充性，尤其是在監管基礎設施分散或過於嚴格的新興經濟體。

這種監管壓力直接導致供應不穩定和市場波動，進一步阻礙了永續成長。在關鍵地區實施禁令政策和嚴格的種植限制往往導致原料供應嚴重短缺。根據聯合國毒品犯罪防制署（UNODC）的數據，截至2024年11月，由於嚴格執行種植禁令，阿富汗的鴉片產量比2022年水準下降了93%。這種嚴格的監管干預迫使全球市場依賴有限的替代來源，造成供應瓶頸和價格波動，限制了整個產業的發展。

市場趨勢

為了滿足現代藥物製劑的特定需求，該行業正在加速高蒂巴因含量和非麻醉性罌粟品種的商業化，超越傳統的氫可酮萃取方式。這項轉變的驅動力在於，蒂巴因等生物鹼作為半合成鴉片類藥物以及那可汀在腫瘤治療和止咳藥中的應用日益廣泛，這迫使大型加工商重新評估其種植合約策略。根據《塔斯馬尼亞鄉村報》（2025年5月）通報，Extractus Biosciences計劃在2025年種植約9,000公頃罌粟。這是由於奧利帕文嚴重短缺，以及對高那可汀含量品種的需求增加，需要將種植面積擴大一倍。這種多元化經營使製造商能夠在滿足特定治療需求的同時，降低氫可酮市場供應過剩的風險。

同時，大型製藥公司正在加速推動生產能力的垂直整合，以確保麻醉藥品原料（NRM）的穩定合規供應。在獲得許可的種植區內直接建造加工基礎設施，可以最大限度地降低物流成本，並加強對從種子到成品的整個供應鏈的監管，以符合嚴格的國際配額要求。根據《經濟時報》（2025年12月）報道，太陽製藥工業有限公司已核准投資300億印度盧比，在中央邦新建一座待開發區的藥品生產廠。此舉具有戰略意義，將使生產更靠近印度主要的合法鴉片產區。這種整合將確保在面對地緣政治供應中斷和監管波動時，業務永續營運。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章：全球鴉片市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（固態，溶劑）
    • 用途（麻醉、染色等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美鴉片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲鴉片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區鴉片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲鴉片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美鴉片市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球鴉片市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Temad Co.
  • Noramco Inc
  • Extractas Bioscience
  • Sun Pharmaceutical Industries
  • GlaxoSmithKline（GSK）opiates business
  • Johnson & Johnson
  • Alcaliber SA
  • API Labs Inc.
  • Bajaj Healthcare Ltd
  • Aesica

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 18795

The Global Opium Market is projected to expand from USD 9.38 Billion in 2025 to USD 12.51 Billion by 2031, registering a CAGR of 4.92%. Opium is characterized as the air-dried latex harvested from the unripe seed capsules of the Papaver somniferum plant, providing essential alkaloids like morphine and codeine that function as critical raw materials for the pharmaceutical sector. The primary factors propelling market growth include the rising global prevalence of chronic pain conditions and the increasing necessity for effective palliative care driven by an aging population. Furthermore, the advancement of oncology treatments demands rigorous pain management protocols, ensuring a sustained industrial requirement for opiate-based analgesics that extends beyond temporary market fluctuations.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.38 Billion
Market Size 2031USD 12.51 Billion
CAGR 2026-20314.92%
Fastest Growing SegmentSolid
Largest MarketNorth America

Conversely, a major obstacle hindering market expansion is the strict international regulatory framework established to prevent diversion and lower addiction risks. These complex compliance mandates often interrupt supply chains and restrict patient access, particularly within developing regions. Data from the International Narcotics Control Board indicates that in 2025, merely 18 percent of globally manufactured morphine was utilized directly for pain relief, highlighting a significant disparity in medical availability that constrains broader market development.

Market Driver

The rapidly aging global population serves as a primary driver for the opium market, necessitating long-term pain management solutions. As life expectancy rises, the incidence of age-related degenerative disorders increases, thereby maintaining industrial demand for morphine and codeine in chronic care. According to the United Nations' 'World Population Prospects 2024' released in July 2024, the number of individuals aged 65 years or older is expected to grow from 825 million in 2024 to 1.53 billion by 2050, creating a massive patient base requiring consistent analgesic support. This demographic shift compels pharmaceutical manufacturers to secure reliable opium supplies for essential geriatric formulations, ensuring supply chains can meet the escalating healthcare needs of seniors.

Simultaneously, the expansion of palliative care services for oncology and terminal illnesses significantly influences market trajectories. Opioids remain the standard of care for managing severe pain in advanced disease stages, ensuring patient quality of life during treatment. The American Cancer Society's 'Cancer Facts & Figures 2024', published in January 2024, projected over 2 million new cancer cases in the United States alone, emphasizing the growing need for robust pain management protocols. However, supply dynamics are shifting; the United Nations Office on Drugs and Crime reported in its 'World Drug Report 2024' (June 2024) that global opium production declined by 74 percent in 2023 due to cultivation bans in Afghanistan, presenting a complex challenge amidst these rising medical demands.

Market Challenge

Stringent international regulatory frameworks designed to curb illicit diversion and addiction risks present a substantial barrier to the growth of the global opium market. These compliance protocols enforce rigorous oversight throughout the supply chain, requiring manufacturers and distributors to navigate complex licensing procedures and strict import-export quotas. This bureaucratic density significantly raises operational costs and prolongs delivery timelines, stifling the agility of pharmaceutical companies to respond to fluctuating medical needs. Consequently, the high cost of compliance and the administrative burden of securing controlled substance authorizations limit the commercial scalability of opiate-based pain management solutions, particularly in emerging economies where regulatory infrastructure may be fragmented or overly restrictive.

This regulatory pressure directly results in supply instability and market volatility, further hampering sustainable growth. The enforcement of prohibition policies and tight cultivation controls in key regions often triggers severe contractions in raw material availability. According to the United Nations Office on Drugs and Crime, in November 2024, opium production in Afghanistan remained 93 percent below 2022 levels following the rigorous enforcement of cultivation bans. Such drastic regulatory interventions force the global market to rely on a limited number of alternative sources, creating supply bottlenecks and price fluctuations that constrain the broader development of the industry.

Market Trends

The industry is increasingly commercializing high-Thebaine and non-narcotic poppy varieties to meet the specific requirements of modern pharmaceutical formulations, moving beyond traditional morphine extraction. This shift is driven by the rising application of alkaloids like Thebaine in semi-synthetic opioids and Noscapine in oncology and cough suppressants, prompting major processors to adjust their agricultural contracting strategies. According to the Tasmanian Country Newspaper, May 2025, Extractas Bioscience plans to contract close to 9,000 hectares of poppy cultivation for the 2025 season, a doubling of previous acreage necessitated by the critical shortage of Oripavine and increased demand for Noscapine-rich strains. This diversification allows manufacturers to mitigate the risks of oversupplied morphine markets while addressing niche therapeutic needs.

Concurrently, major pharmaceutical firms are accelerating the vertical integration of their manufacturing capabilities to secure a stable and compliant supply of Narcotic Raw Material (NRM). By establishing processing infrastructure directly within licensed cultivation regions, companies can minimize logistics costs and enhance oversight of the sensitive seed-to-shelf supply chain against rigorous international quotas. According to The Economic Times, December 2025, Sun Pharmaceutical Industries approved a capital investment of Rs 3,000 crore to construct a new greenfield formulations manufacturing facility in Madhya Pradesh, a strategic move to proximity-align production with India's primary legal opium tracts. This consolidation ensures operational resilience against geopolitical supply disruptions and regulatory volatility.

Key Market Players

  • Temad Co.
  • Noramco Inc
  • Extractas Bioscience
  • Sun Pharmaceutical Industries
  • GlaxoSmithKline (GSK) opiates business
  • Johnson & Johnson
  • Alcaliber S.A.
  • API Labs Inc.
  • Bajaj Healthcare Ltd
  • Aesica

Report Scope

In this report, the Global Opium Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Opium Market, By Type

  • Solid
  • Solvent

Opium Market, By Application

  • Anesthetized
  • Dyeing
  • Others

Opium Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Opium Market.

Available Customizations:

Global Opium Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Opium Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Solid, Solvent)
    • 5.2.2. By Application (Anesthetized, Dyeing, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Opium Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Opium Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Opium Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Opium Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Opium Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Opium Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Opium Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Opium Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Opium Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Opium Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Opium Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Opium Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Opium Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Opium Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Opium Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Opium Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Opium Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Opium Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Opium Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Opium Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Opium Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Opium Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Opium Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Opium Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Opium Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Temad Co.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Noramco Inc
  • 15.3. Extractas Bioscience
  • 15.4. Sun Pharmaceutical Industries
  • 15.5. GlaxoSmithKline (GSK) opiates business
  • 15.6. Johnson & Johnson
  • 15.7. Alcaliber S.A.
  • 15.8. API Labs Inc.
  • 15.9. Bajaj Healthcare Ltd
  • 15.10. Aesica

16. Strategic Recommendations

17. About Us & Disclaimer